Targeted Combination of Poly(ADP-ribose) Polymerase Inhibitors and Immune Checkpoint Inhibitors Lacking Evidence of Benefit: Focus in Ovarian Cancer Review Article (Web of Science)

cited authors

  • Bailey, Morgan; Morand, Susan; Royfman, Rachel; Lin, Leslie; Singh, Aditi; Stanbery, Laura; Walter, Adam; Hamouda, Danae; Nemunaitis, John

publication date

  • March 1, 2024

webpage

published in

category

keywords

  • BRCA
  • HRD
  • HRP
  • PARP inhibitor
  • checkpoint inhibitor
  • homologous recombination
  • immunotherapy
  • ovarian cancer

volume

  • 25

issue

  • 6